Ramy Abdelnaby: The Impact of Multiterritory Brain Infarcts on Recurrent Stroke Risk and Anticoagulation Efficacy
Ramy Abdelnaby, Consultant Neurologist / Oberarzt at RWTH Aachen University Hospital, shared on LinkedIn about a recent article by Rachel Gologorsky et al, published in Stroke Journal:
”A pivotal subgroup analysis of the ARCADIA trial, recently published in Stroke, illuminates the impact of multiterritory brain infarcts on recurrent stroke risk and the efficacy of anticoagulation in cryptogenic stroke patients.
The comprehensive study spanned from 2018 to 2022 across 185 centers, exploring atrial cardiopathy’s role in stroke recurrence and anticoagulation response.
Key findings reveal no significant association between atrial cardiopathy biomarkers, LVEF, and the number of infarct territories.
Yet, it’s the detailed examination of recurrent stroke risk and anticoagulation effects that promises to redefine clinical strategies.”
Title: Multiterritory Brain Infarcts, Anticoagulation, and Recurrence After Cryptogenic Stroke: A Subgroup Analysis of the ARCADIA Trial
Authors: Rachel Gologorsky, Maarten G. Lansberg, Max Wintermark, Christy N. Cassarly, Rebeca Aragon Garcia, Pamela Plummer, Nilushi Karunamuni, Scott E. Kasner, Babak B. Navi, Ava Liberman, Mukul Sharma, Joseph P. Broderick, W.T. Longstreth Jr., David L. Tirschwell, Richard A. Kronmal, Mitchell S.V. Elkind, Hooman Kamel
Read the Full Article on Stroke
Stay updated on all scientific advances with Hemostasis Today.
-
Jun 12, 2026, 14:40Daniel Auclair: Hematocure Team Shines at EHA 2026
-
Jun 12, 2026, 14:27Aoife Brennan: Ongoing Budo Study Demonstrates Potential in Challenging ITP Population
-
Jun 12, 2026, 14:15Shahram Kordasti: A Well-Deserved Honor at EHA 2026
-
Jun 12, 2026, 14:12Ahvie Herskowitz: Beyond Weight Loss – Lessons From the GLP-1 Era
-
Jun 12, 2026, 14:06Elizabeth Clift: Pride Month Through the Lens of Haemophilia
-
Jun 12, 2026, 13:46Katherine Simbaña Rivera: Understanding Thromboembolic Risk After COVID-19
-
Jun 12, 2026, 13:38Bruna Velosa Ferreira: Lessons in Leadership, Mentorship, and Humanity from EHA 2026
-
Jun 12, 2026, 13:33Astha Thakkar: Understanding Anti-Platelets vs. Anti-Coagulants – When to Use Which?
-
Jun 12, 2026, 13:21Walaa Abuelmagd: Honoring Excellence and Inclusion at the EHA 2026 Congress